Roivant Sciences Ltd. (ROIV) Price and Market Data

Roivant Sciences Ltd. is a commercial-stage biopharmaceutical company focused on improving healthcare delivery for patients. In addition to its core biopharma operations, the company incubates discovery-stage businesses and health technology startups that complement its broader platform. Its commercial drug candidate, VTAMA (tapinarof), is approved for the treatment of plaque psoriasis in adult patients. Roivant also has a pipeline of other drug candidates at various stages of development, including Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.